These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 17159925)

  • 1. Why is cancer drug discovery so difficult?
    Kamb A; Wee S; Lengauer C
    Nat Rev Drug Discov; 2007 Feb; 6(2):115-20. PubMed ID: 17159925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new era in cancer therapeutics?
    Westwell AD
    Drug Discov Today; 2003 Jan; 8(2):64-5. PubMed ID: 12565007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer treatment. New drugs, new hope.
    Harv Health Lett; 2001 Jul; 26(9):1-3. PubMed ID: 11511447
    [No Abstract]   [Full Text] [Related]  

  • 4. Gold standard or wrong standard?
    Oldham R; Dillman R
    Cancer Biother Radiopharm; 2004 Jun; 19(3):271-2. PubMed ID: 15285873
    [No Abstract]   [Full Text] [Related]  

  • 5. Imatinib mesylate for melanoma: will a new target be revealed?
    Grossman D
    J Invest Dermatol; 2004 Dec; 123(6):xi-xiii. PubMed ID: 15610499
    [No Abstract]   [Full Text] [Related]  

  • 6. [Optimizing current drugs].
    Blay JY
    Ann Pharm Fr; 2005 Jan; 63(1):17-24. PubMed ID: 15803096
    [No Abstract]   [Full Text] [Related]  

  • 7. Response to imatinib mesylate depends on the presence of the V559A-mutated KIT oncogene.
    Terheyden P; Houben R; Pajouh P; Thorns C; Zillikens D; Becker JC
    J Invest Dermatol; 2010 Jan; 130(1):314-6. PubMed ID: 19812602
    [No Abstract]   [Full Text] [Related]  

  • 8. Imatinib for chronic myeloid leukaemia: a NICE mess.
    Barbour V
    Lancet; 2001 Nov; 358(9292):1478. PubMed ID: 11705557
    [No Abstract]   [Full Text] [Related]  

  • 9. A new KIT gene mutation in thymic cancer and a promising response to imatinib.
    Lim SH; Lee JY; Sun JM; Kim KM; Ahn JS; Ahn MJ; Park K
    J Thorac Oncol; 2013 Oct; 8(10):e91-2. PubMed ID: 24457249
    [No Abstract]   [Full Text] [Related]  

  • 10. Gastrointestinal stromal tumor with metastases in an adult woman treated with imatinib mesylate: MDCT findings.
    Busalacchi PJ; de la Calle MA; Torroba A; Del Río ST
    AJR Am J Roentgenol; 2005 Mar; 184(3 Suppl):S58-61. PubMed ID: 15728023
    [No Abstract]   [Full Text] [Related]  

  • 11. Secondary resistance to imatinib mesylate in a patient with unresectable duodenal GIST without mutations in exons 9, 11, 13, or 17 of the c-kit protooncogene.
    Yamaguchi M; Matsumoto T; Tate G; Higuchi T
    J Gastroenterol; 2004 Sep; 39(9):904-5. PubMed ID: 15565413
    [No Abstract]   [Full Text] [Related]  

  • 12. Imatinib: as adjuvant therapy for gastrointestinal stromal tumor†: profile report.
    Sanford M; Scott LJ
    BioDrugs; 2011 Jun; 25(3):191-2. PubMed ID: 21627342
    [No Abstract]   [Full Text] [Related]  

  • 13. [Autophagy in hematologic malignancies].
    Adachi S
    Rinsho Ketsueki; 2009 Oct; 50(10):1531-8. PubMed ID: 19915363
    [No Abstract]   [Full Text] [Related]  

  • 14. New agents in cancer clinical trials.
    Adams J; Elliott PJ
    Oncogene; 2000 Dec; 19(56):6687-92. PubMed ID: 11426656
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical manifestation of targeted drugs in individualized therapy of malignant tumors].
    Chu DT
    Zhonghua Zhong Liu Za Zhi; 2010 Oct; 32(10):721-4. PubMed ID: 21163058
    [No Abstract]   [Full Text] [Related]  

  • 16. Highlighting the role of FDG PET scan in early response assessment of gastrointestinal stromal tumor treated with imatinib mesylate.
    Abhyankar SA; Nair N
    Clin Nucl Med; 2008 Mar; 33(3):213-4. PubMed ID: 18287851
    [No Abstract]   [Full Text] [Related]  

  • 17. Sunitinib for imatinib-resistant GIST.
    Joensuu H
    Lancet; 2006 Oct; 368(9544):1303-4. PubMed ID: 17046443
    [No Abstract]   [Full Text] [Related]  

  • 18. a suitable case for treatment. The National Institute for Clinical Excellence's change of heart over cancer drug Glivec has been applauded by clinicians--and patients.
    Siddall R
    Health Serv J; 2002 Aug; 112(5819):10. PubMed ID: 12356018
    [No Abstract]   [Full Text] [Related]  

  • 19. First report of a complete pathological response of a pelvic GIST treated with imatinib as neoadjuvant therapy.
    Salazar M; Barata A; André S; Venâncio J; Francisco I; Cravo M; Nobre-Leitão C
    Gut; 2006 Apr; 55(4):585-6. PubMed ID: 16531543
    [No Abstract]   [Full Text] [Related]  

  • 20. Imatinib for chronic myeloid leukaemia: a NICE mess.
    Rajaratnam G; Edwards J
    Lancet; 2001 Dec; 358(9296):1902. PubMed ID: 11741655
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.